Literature DB >> 29496992

Distinct functions for the membrane-proximal ectodomain region (MPER) of HIV-1 gp41 in cell-free and cell-cell viral transmission and cell-cell fusion.

Vani G S Narasimhulu1,2, Anna K Bellamy-McIntyre1,3, Annamarie E Laumaea1,2, Chan-Sien Lay4, David N Harrison1, Hannah A D King1,2, Heidi E Drummer1,2,3, Pantelis Poumbourios5,3,4.   

Abstract

HIV-1 is spread by cell-free virions and by cell-cell viral transfer. We asked whether the structure and function of a broad neutralizing antibody (bNAb) epitope, the membrane-proximal ectodomain region (MPER) of the viral gp41 transmembrane glycoprotein, differ in cell-free and cell-cell-transmitted viruses and whether this difference could be related to Ab neutralization sensitivity. Whereas cell-free viruses bearing W666A and I675A substitutions in the MPER lacked infectivity, cell-associated mutant viruses were able to initiate robust spreading infection. Infectivity was restored to cell-free viruses by additional substitutions in the cytoplasmic tail (CT) of gp41 known to disrupt interactions with the viral matrix protein. We observed contrasting effects on cell-free virus infectivity when W666A was introduced to two transmitted/founder isolates, but both mutants could still mediate cell-cell spread. Domain swapping indicated that the disparate W666A phenotypes of the cell-free transmitted/founder viruses are controlled by sequences in variable regions 1, 2, and 4 of gp120. The sequential passaging of an MPER mutant (W672A) in peripheral blood mononuclear cells enabled selection of viral revertants with loss-of-glycan suppressor mutations in variable region 1, suggesting a functional interaction between variable region 1 and the MPER. An MPER-directed bNAb neutralized cell-free virus but not cell-cell viral spread. Our results suggest that the MPER of cell-cell-transmitted virions has a malleable structure that tolerates mutagenic disruption but is not accessible to bNAbs. In cell-free virions, interactions mediated by the CT impose an alternative MPER structure that is less tolerant of mutagenic alteration and is efficiently targeted by bNAbs.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cell–cell transmission; glycoprotein; human immunodeficiency virus (HIV); membrane fusion; mutant; neutralization; viral replication; virus entry

Mesh:

Substances:

Year:  2018        PMID: 29496992      PMCID: PMC5912456          DOI: 10.1074/jbc.RA117.000537

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  145 in total

1.  Plasma membrane rafts play a critical role in HIV-1 assembly and release.

Authors:  A Ono; E O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

Review 2.  How proteins adapt to a membrane-water interface.

Authors:  J A Killian; G von Heijne
Journal:  Trends Biochem Sci       Date:  2000-09       Impact factor: 13.807

3.  A tyrosine-based motif in the HIV-1 envelope glycoprotein tail mediates cell-type- and Rab11-FIP1C-dependent incorporation into virions.

Authors:  Mingli Qi; Hin Chu; Xuemin Chen; Junghwa Choi; Xiaoyun Wen; Jason Hammonds; Lingmei Ding; Eric Hunter; Paul Spearman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-01       Impact factor: 11.205

4.  Origin of the U87MG glioma cell line: Good news and bad news.

Authors:  Marie Allen; Mia Bjerke; Hanna Edlund; Sven Nelander; Bengt Westermark
Journal:  Sci Transl Med       Date:  2016-08-31       Impact factor: 17.956

5.  HIV-1 clinical isolates resistant to CCR5 antagonists exhibit delayed entry kinetics that are corrected in the presence of drug.

Authors:  Opass Putcharoen; Sun Hee Lee; Timothy J Henrich; Zixin Hu; Jakapat Vanichanan; Eoin Coakley; Wayne Greaves; Roy M Gulick; Daniel R Kuritzkes; Athe M N Tsibris
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

6.  Trimer Enhancement Mutation Effects on HIV-1 Matrix Protein Binding Activities.

Authors:  Ayna Alfadhli; Andrew Mack; Christopher Ritchie; Isabel Cylinder; Logan Harper; Philip R Tedbury; Eric O Freed; Eric Barklis
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

7.  Maturation-dependent HIV-1 surface protein redistribution revealed by fluorescence nanoscopy.

Authors:  Jakub Chojnacki; Thorsten Staudt; Bärbel Glass; Pit Bingen; Johann Engelhardt; Maria Anders; Jale Schneider; Barbara Müller; Stefan W Hell; Hans-Georg Kräusslich
Journal:  Science       Date:  2012-10-26       Impact factor: 47.728

8.  A conserved dileucine motif mediates clathrin and AP-2-dependent endocytosis of the HIV-1 envelope protein.

Authors:  Rahel Byland; Patricia J Vance; James A Hoxie; Mark Marsh
Journal:  Mol Biol Cell       Date:  2006-11-15       Impact factor: 4.138

9.  Forced virus evolution reveals functional crosstalk between the disulfide bonded region and membrane proximal ectodomain region of HIV-1 gp41.

Authors:  Ashraf I Khasawneh; Annemarie Laumaea; David N Harrison; Anna K Bellamy-McIntyre; Heidi E Drummer; Pantelis Poumbourios
Journal:  Retrovirology       Date:  2013-04-23       Impact factor: 4.602

10.  Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission.

Authors:  Marine Malbec; Françoise Porrot; Rejane Rua; Joshua Horwitz; Florian Klein; Ari Halper-Stromberg; Johannes F Scheid; Caroline Eden; Hugo Mouquet; Michel C Nussenzweig; Olivier Schwartz
Journal:  J Exp Med       Date:  2013-11-25       Impact factor: 14.307

View more
  7 in total

1.  Topological analysis of the gp41 MPER on lipid bilayers relevant to the metastable HIV-1 envelope prefusion state.

Authors:  Yi Wang; Pavanjeet Kaur; Zhen-Yu J Sun; Mostafa A Elbahnasawy; Zahra Hayati; Zhi-Song Qiao; Nhat N Bui; Camila Chile; Mahmoud L Nasr; Gerhard Wagner; Jia-Huai Wang; Likai Song; Ellis L Reinherz; Mikyung Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-17       Impact factor: 11.205

2.  Extracellular vesicles originating from autophagy mediate an antibody-resistant spread of classical swine fever virus in cell culture.

Authors:  Tao Wang; Liang Zhang; Wulong Liang; Shanchuan Liu; Wen Deng; Yangruiyu Liu; Yaru Liu; Mengzhao Song; Kangkang Guo; Yanming Zhang
Journal:  Autophagy       Date:  2021-11-05       Impact factor: 13.391

3.  Mechanistic Analysis of the Broad Antiretroviral Resistance Conferred by HIV-1 Envelope Glycoprotein Mutations.

Authors:  Yuta Hikichi; Rachel Van Duyne; Phuong Pham; Jennifer L Groebner; Ann Wiegand; John W Mellors; Mary F Kearney; Eric O Freed
Journal:  mBio       Date:  2021-01-12       Impact factor: 7.867

4.  The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic.

Authors:  Priyanka Shah; Gabriela A Canziani; Erik P Carter; Irwin Chaiken
Journal:  Front Immunol       Date:  2021-03-09       Impact factor: 8.786

5.  Structure of HIV-1 gp41 with its membrane anchors targeted by neutralizing antibodies.

Authors:  Christophe Caillat; Delphine Guilligay; Johana Torralba; Nikolas Friedrich; Jose L Nieva; Alexandra Trkola; Christophe J Chipot; François L Dehez; Winfried Weissenhorn
Journal:  Elife       Date:  2021-04-19       Impact factor: 8.140

6.  Cell membrane-anchored anti-HIV single-chain antibodies and bifunctional inhibitors targeting the gp41 fusion protein: new strategies for HIV gene therapy.

Authors:  Yue Chen; Hongliang Jin; Xiaoran Tang; Li Li; Xiuzhu Geng; Yuanmei Zhu; Huihui Chong; Yuxian He
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

7.  Peptide Triazole Thiol Irreversibly Inactivates Metastable HIV-1 Env by Accessing Conformational Triggers Intrinsic to Virus-Cell Entry.

Authors:  Charles Gotuaco Ang; Erik Carter; Ann Haftl; Shiyu Zhang; Adel A Rashad; Michele Kutzler; Cameron F Abrams; Irwin M Chaiken
Journal:  Microorganisms       Date:  2021-06-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.